Current state of hemp and cannabis
The FDA’s still deciding whether cannabis is medicine or Schedule I contraband, while patients quietly self-titrate in states where it’s apparently more legal than aspirin. Clinical evidence moves slower than the regulatory apparatus, which…
MMJ International Holdings Seeks Injunction to Halt CMS CBD Program | Newswire
MMJ International Holdings has filed for a cms cbd program injunction to block a Centers for Medicare and Medicaid Services initiative. This legal action raises critical questions about regulatory oversight of cannabidiol products in Medicare. The…
Cannabis Companies Pull Back Investments in Hartford Amid Market Changes
Connecticut cannabis market pullback reflects regulatory challenges impacting patient access to cannabis products. Companies are reducing investments amid market uncertainties. Clinicians should monitor these changes to support patient care.
Is The DEA Still Stuck In The Reefer Madness Era? About Weed! | Cbd Oil Lotion Whole Foods
DEA cannabis policy updates continue to influence patient access to cannabis medicine and research opportunities. Understanding these changes is crucial for clinicians navigating current legal frameworks. This article highlights the ongoing challenges…
Ontario Government Considers Expanding Cannabis Sale Hours
Ontario cannabis retail hours expansion is under consideration to improve patient access to medical cannabis. Extended hours could benefit patients with conflicting work schedules. This policy change may influence consumption patterns and adherence.
Policy Watch: 10 Regulatory Updates — April 12, 2026
This April 2026 update covers synthetic cannabinoids Schedule I placement by the DEA, highlighting key regulatory changes. Cannabis clinicians should note the impact on legal treatment options. These regulatory updates clarify distinctions between…
Alabama’s First Cannabis Dispensary Launches in Montgomery This Year
The Alabama cannabis dispensary opening 2026 in Montgomery marks a pivotal moment for patient access to regulated cannabis products. This launch introduces standardized, tested cannabis options for Alabama patients. Clinicians now have an opportunity to…
Ontario Weighs Earlier Opening for Cannabis Stores
Ontario is considering expanded retail hours cannabis access to improve patient convenience and safety. Earlier store openings could benefit those managing morning symptoms or complex dosing. This regulatory change aims to reduce barriers to licensed…
Temporary Halt on THC Ban in Texas by Judge
A judge temporarily halts THC ban Texas, marking a significant legal development. This decision affects cannabis medicine and clinical practice in the state. Clinicians should monitor this evolving situation closely.
Bloom Enters Pennsylvania Medical Cannabis Market With Cresco – MyChesCo
Bloom's entry into the Pennsylvania medical cannabis market with Cresco is a notable development in cannabis medicine. Clinicians should monitor emerging evidence related to this market expansion. This update highlights important clinical relevance for…